Epidemiological studies have identified positive associations between PD and an increased risk of malignant brain tumors [170,171], while genetic studies have shown that mutations in the human E3–ubiquitin ligase–coding gene PARK2 are associated with several malignancies in addition to early onset PD [172]. This evidence concerns the gene PRKN and Parkinson disease.